Literature DB >> 18677555

Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect.

Andrew M Campbell1, Samuel H P Chan.   

Abstract

Normal cells of aerobic organisms synthesize the energy they require in the form of ATP via the process of oxidative phosphorylation. This complex system resides in the mitochondria of cells and utilizes oxygen to produce a majority of cellular ATP. However, in most tumors, especially those with elevated cholesterogenesis, there is an increased reliance on glycolysis for energy, even in conditions where oxygen is available. This aerobic glycolysis (the Warburg effect) has far reaching ramifications on the tumor itself and the cells that surround it. In this brief review, we will discuss how abnormally high membrane cholesterol levels can result in a subsequent deficiency of oxidative energy production in mitochondria from cultured Morris hepatoma cells (MH-7777). We have identified the voltage dependent anion channel (VDAC) as a necessary component of a protein complex involved in mitochondrial membrane cholesterol distribution and transport. Work in our laboratory demonstrates that the ability of VDAC to influence mitochondrial membrane cholesterol distribution may have implications on mitochondrial characteristics such as oxidative phosphorylation and induction of apoptosis, as well as the propensity of cancer cells to exhibit a glycolytic phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677555     DOI: 10.1007/s10863-008-9138-x

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  44 in total

Review 1.  Mitochondria: a target for cancer therapy.

Authors:  Jeffrey S Armstrong
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

Authors:  Sébastien Bonnet; Stephen L Archer; Joan Allalunis-Turner; Alois Haromy; Christian Beaulieu; Richard Thompson; Christopher T Lee; Gary D Lopaschuk; Lakshmi Puttagunta; Sandra Bonnet; Gwyneth Harry; Kyoko Hashimoto; Christopher J Porter; Miguel A Andrade; Bernard Thebaud; Evangelos D Michelakis
Journal:  Cancer Cell       Date:  2007-01       Impact factor: 31.743

Review 3.  Cholesterol metabolism and tumor cell proliferation.

Authors:  P S Coleman; L C Chen; L Sepp-Lorenzino
Journal:  Subcell Biochem       Date:  1997

4.  Energy substrate utilization in freshly isolated Morris Hepatoma 7777 cells.

Authors:  J A Mares-Perlman; E Shrago
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

Review 5.  Drugs targeting mitochondrial functions to control tumor cell growth.

Authors:  Nathalie Dias; Christian Bailly
Journal:  Biochem Pharmacol       Date:  2005-07-01       Impact factor: 5.858

6.  Nucleotide-binding sites in the voltage-dependent anion channel: characterization and localization.

Authors:  Galit Yehezkel; Nurit Hadad; Hilal Zaid; Sara Sivan; Varda Shoshan-Barmatz
Journal:  J Biol Chem       Date:  2005-12-14       Impact factor: 5.157

Review 7.  Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis.

Authors:  Saroj P Mathupala; Chaim B Colen; Prahlad Parajuli; Andrew E Sloan
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 2.945

Review 8.  Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

Review 9.  Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization.

Authors:  H Kondoh; M E Lleonart; D Bernard; J Gil
Journal:  Histol Histopathol       Date:  2007-01       Impact factor: 2.303

10.  Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death.

Authors:  Christopher P Baines; Robert A Kaiser; Tatiana Sheiko; William J Craigen; Jeffery D Molkentin
Journal:  Nat Cell Biol       Date:  2007-04-08       Impact factor: 28.824

View more
  17 in total

Review 1.  Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function.

Authors:  Laura A Martin; Barry E Kennedy; Barbara Karten
Journal:  J Bioenerg Biomembr       Date:  2014-11-26       Impact factor: 2.945

2.  The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism.

Authors:  Stephanos Pavlides; Aristotelis Tsirigos; Gemma Migneco; Diana Whitaker-Menezes; Barbara Chiavarina; Neal Flomenberg; Philippe G Frank; Mathew C Casimiro; Chenguang Wang; Richard G Pestell; Ubaldo E Martinez-Outschoorn; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-09-01       Impact factor: 4.534

3.  Ouabain targets the unfolded protein response for selective killing of HepG2 cells during glucose deprivation.

Authors:  Tulay Ozdemir; Rukiye Nar; Veli Kilinc; Hasan Alacam; Osman Salis; Aynur Duzgun; Sedat Gulten; Abdulkerim Bedir
Journal:  Cancer Biother Radiopharm       Date:  2012-07-03       Impact factor: 3.099

4.  Examination of the brain mitochondrial lipidome using shotgun lipidomics.

Authors:  Michael A Kiebish; Xianlin Han; Thomas N Seyfried
Journal:  Methods Mol Biol       Date:  2009

5.  MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.

Authors:  Feiran Wang; Yong Qiang; Lirong Zhu; Yasu Jiang; Yinda Wang; Xian Shao; Lei Yin; Jiahui Chen; Zhong Chen
Journal:  Tumour Biol       Date:  2016-01-30

6.  VDAC1: from structure to cancer therapy.

Authors:  Varda Shoshan-Barmatz; Dario Mizrachi
Journal:  Front Oncol       Date:  2012-11-29       Impact factor: 6.244

7.  Systems-scale analysis reveals pathways involved in cellular response to methamphetamine.

Authors:  Lijie Sun; Hong-Mei Li; Manfredo J Seufferheld; Kent R Walters; Venu M Margam; Amber Jannasch; Naomi Diaz; Catherine P Riley; Weilin Sun; Yueh-Feng Li; William M Muir; Jun Xie; Jing Wu; Fan Zhang; Jake Y Chen; Eric L Barker; Jiri Adamec; Barry R Pittendrigh
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

8.  Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo.

Authors:  Tasleem Arif; Lilia Vasilkovsky; Yael Refaely; Alexander Konson; Varda Shoshan-Barmatz
Journal:  Mol Ther Nucleic Acids       Date:  2014-04-29       Impact factor: 10.183

9.  The vitamin D receptor inhibits the respiratory chain, contributing to the metabolic switch that is essential for cancer cell proliferation.

Authors:  Marco Consiglio; Michele Destefanis; Deborah Morena; Valentina Foglizzo; Mattia Forneris; Gianpiero Pescarmona; Francesca Silvagno
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

10.  Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death.

Authors:  N Rimmerman; D Ben-Hail; Z Porat; A Juknat; E Kozela; M P Daniels; P S Connelly; E Leishman; H B Bradshaw; V Shoshan-Barmatz; Z Vogel
Journal:  Cell Death Dis       Date:  2013-12-05       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.